CN1098624A - 用于预防酒精中毒的药物制剂及其制备方法 - Google Patents

用于预防酒精中毒的药物制剂及其制备方法 Download PDF

Info

Publication number
CN1098624A
CN1098624A CN94104765A CN94104765A CN1098624A CN 1098624 A CN1098624 A CN 1098624A CN 94104765 A CN94104765 A CN 94104765A CN 94104765 A CN94104765 A CN 94104765A CN 1098624 A CN1098624 A CN 1098624A
Authority
CN
China
Prior art keywords
aspartate
altheine
pharmaceutical preparation
ethanol
soup
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN94104765A
Other languages
English (en)
Chinese (zh)
Inventor
朴相哲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daesang Corp
Original Assignee
Miwon Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26629748&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN1098624(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Miwon Co Ltd filed Critical Miwon Co Ltd
Publication of CN1098624A publication Critical patent/CN1098624A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/334—Foods, ingredients or supplements having a functional effect on health treating the effects of consuming alcohol, narcotics or other addictive behavior, e.g. treating hangover or reducing blood alcohol levels
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/02—Acid
    • A23V2250/06—Amino acid
    • A23V2250/0608—Asparagine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Seasonings (AREA)
CN94104765A 1993-06-28 1994-05-02 用于预防酒精中毒的药物制剂及其制备方法 Pending CN1098624A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR11849/93 1993-06-28
KR930011849 1993-06-28
KR26324/93 1993-12-03
KR1019930026324A KR970008105B1 (ko) 1993-06-28 1993-12-03 L-아스파테이트 또는 아스파라긴을 유효성분으로 함유하는 알콜성 장해 보호제 및 그의 제조방법

Publications (1)

Publication Number Publication Date
CN1098624A true CN1098624A (zh) 1995-02-15

Family

ID=26629748

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94104765A Pending CN1098624A (zh) 1993-06-28 1994-05-02 用于预防酒精中毒的药物制剂及其制备方法

Country Status (7)

Country Link
US (1) US5389359A (enExample)
EP (1) EP0631778A1 (enExample)
JP (1) JPH0753366A (enExample)
KR (1) KR970008105B1 (enExample)
CN (1) CN1098624A (enExample)
BR (1) BR9401354A (enExample)
TW (1) TW278035B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020088734A (ko) * 2001-05-21 2002-11-29 엄경용 숙취 해소용 조성물
JPWO2006061992A1 (ja) * 2004-12-10 2008-06-05 味の素株式会社 肝疾患予防・治療用組成物
JP2007020432A (ja) * 2005-07-13 2007-02-01 Asahi Breweries Ltd アルコール代謝促進飲料
US7565555B2 (en) * 2005-11-23 2009-07-21 Cisco Technology, Inc. Uninterruptible power supply resource sharing for multiple power sourcing equipment network devices
WO2007142297A1 (ja) * 2006-06-09 2007-12-13 Ajinomoto Co., Inc. 肝疾患予防・治療用組成物
IT1395957B1 (it) * 2009-05-19 2012-11-02 Pharmaguida S R L Uso di una combinazione di d-aspartato e l-aspartato per il trattamento della infertilita' maschile.
WO2013168694A1 (ja) * 2012-05-07 2013-11-14 株式会社明治 非糖質性エネルギー産生増強剤
US9161957B2 (en) 2012-08-03 2015-10-20 Life Well Lived, Llc Compositions and methods for reducing blood alcohol content
WO2015008101A1 (en) 2013-07-15 2015-01-22 Schaumlöffel Rolf A Composition of a drink for enhanced reduction of blood alcohol level
JP7729036B2 (ja) * 2020-12-21 2025-08-26 味の素株式会社 アスパラギン酸又はその塩を主成分とする粉粒体経口組成物

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3009859A (en) * 1958-07-22 1961-11-21 Laborit Henri Potassium aspartate and magnesium aspartate fatigue-recovery promoting process and compositions
GB949076A (en) * 1961-08-10 1964-02-12 Wesley Gale Irons Preparation of polypeptide derivatives
GB1066084A (en) * 1963-05-08 1967-04-19 Kyowa Hakko Kogyo Kk Improved alcoholic beverages
GB1068478A (en) * 1963-07-30 1967-05-10 Kyowa Hakko Kogyo Kk Increasing amino-acid content of food
RO55542A2 (enExample) * 1971-02-27 1973-09-20
CA1057568A (en) * 1974-06-10 1979-07-03 General Foods Corporation Soluble sweetening composition and method
FR2310708A1 (fr) * 1975-05-16 1976-12-10 Sopharga Lab Nouvelles boissons sans alcools
US4479974A (en) * 1982-10-19 1984-10-30 General Foods Corporation Amino acids as dry beverage mix ingredients
GB8325627D0 (en) * 1983-09-24 1983-10-26 Scras Therapeutic compositions
US4913923A (en) * 1984-09-12 1990-04-03 Firmenich Sa Process for improving or modifying the taste and aroma of citrus fruit compositions
US4738856A (en) * 1985-05-13 1988-04-19 Nutrition Technologies, Inc. Beverage and method for making a beverage for the nutritional supplementation of calcium in humans
US4997672A (en) * 1987-03-10 1991-03-05 Virginia Commonwealth University Salt taste enhancer
WO1989004165A1 (en) * 1987-10-19 1989-05-18 Haklitch Joseph A Detoxifying food supplement
IT1219919B (it) * 1988-04-11 1990-05-24 Foscama Biomed Chim Farma Impiego del fruttosio-1,6-difosfato nel trattamento della intossicazione alcolica acuta e dell' etilismo cronico e composizioni farmaceutiche relative
US4992282A (en) * 1989-05-08 1991-02-12 The Procter & Gamble Company Stable nutritional vitamin and mineral supplemented beverage
AT394493B (de) * 1989-05-11 1992-04-10 Homosan Ag Pharmazeutisches praeparat zur behandlung von lebererkrankungen
HU207800B (en) * 1990-05-10 1993-06-28 Andras Sikter Process for producing composition for improving condition and for treating different illnesses
US5145707A (en) * 1991-12-12 1992-09-08 Kraft General Foods, Inc. Salt enhancer
US5176934A (en) * 1991-12-12 1993-01-05 Kraft General Foods, Inc. Seasoned food product with a salt enhancer
KR930012028A (ko) * 1991-12-19 1993-07-20 박용성 생약제제

Also Published As

Publication number Publication date
BR9401354A (pt) 1995-03-07
KR970008105B1 (ko) 1997-05-21
EP0631778A1 (en) 1995-01-04
US5389359A (en) 1995-02-14
JPH0753366A (ja) 1995-02-28
TW278035B (enExample) 1996-06-11
KR950000143A (ko) 1995-01-03

Similar Documents

Publication Publication Date Title
Evans et al. Composition and biological activity of chromium-pyridine carboxylate complexes
JP5762396B2 (ja) 糖尿病療法の支援のためのα−ケト酸を含有する栄養補助剤
HUE032486T2 (en) An improved method for administering beta-hydroxy-beta-methylbutyrate (HMB)
CN101076253A (zh) 宿醉治疗和减轻酒精的组合物
US12350243B2 (en) Compositions and compounds containing beta-hydroxybutyrate and one or more amino acids
CN1098624A (zh) 用于预防酒精中毒的药物制剂及其制备方法
CN106820093A (zh) 一种适用于马拉松和长跑运动使用的能量胶及其制备方法
Xia et al. Comparative metabolomics and microbial communities associated network analysis of black and white horse-sourced koumiss
Verger et al. Effects of administration of branched-chain amino acids vs. glucose during acute exercise in the rat
CN101822401B (zh) 一种具有缓解疲劳功能的饮料
Swensen et al. Adding polylactate to a glucose polymer solution does not improve endurance
CN104415023A (zh) 预防或/和治疗胰岛素抵抗及相关病症的组合物
McMahon et al. Methamphetamine-induced insulin release
Birkhahn et al. Interaction of ketosis and liver regeneration in the rat
US20060251732A1 (en) Crystalloid electrolyte water formulation
CN113197884A (zh) α-酮丁酸在制备预防和/或治疗非酒精性脂肪肝的药物中的应用
Birkhahn et al. Parenteral monoacetoacetin and liver regeneration interaction after partial hepatectomy in the rat
US20250332128A1 (en) Compositions and compounds containng ketone bodies and/or ketone body precursors and one or more amino acids
EP0078859B1 (en) An antianaemic agent and a process for producing the same
CN101559064A (zh) 一种可以保护细胞膜的药物
Giesecke et al. RU ME II ACIDOSIS AND METABOLIC KINETICS OF D (-) LACTIC ACID
ZELMAN et al. Cytochrome c therapy of tissue anoxia in a case of hepatolenticular degeneration
KR100559100B1 (ko) 훈련 유도 서맥을 강화시키기 위한 카르니틴의 용도
JP4772295B2 (ja) 共役脂肪酸を有効成分とする運動能力改善剤
Douglas Kalman., et al.“A Randomized Double-Blind Evaluation of the Gastrointestinal, Body Composition, Stress Response and Cognitive Function Impacts of Creatine Supplementation in Healthy Adults”

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication